Skip to main content

Ozempic News (Page 3)

'Hungry Gut' Gene Test Shows Who'll Benefit Most From Wegovy

TUESDAY, May 21, 2024 – You've watched others shed pounds in a matter of weeks after taking one of the new blockbuster weight-loss drugs, so you decide to try one of the medications yourself, only...

Semaglutide Has Lasting Benefit for Weight Loss

TUESDAY, May 21, 2024 – Semaglutide has a long-term beneficial impact on weight, as well as cardiovascular benefits, regardless of weight loss, according to two studies presented at the annual...

Stomach Paralysis Risk May Rise in People Taking Ozempic and Similar Drugs

MONDAY, May 20, 2024 – New, real-world research confirms that the blockbuster weight-loss drugs that millions of Americans have been taking to shed pounds can trigger stomach paralysis in some...

Semaglutide Reduces Need for Diuretics in Heart Failure

THURSDAY, May 16, 2024 – Semaglutide reduces the need for loop diuretics and has positive effects on symptoms, physical limitations, and body weight in patients with heart failure with preserved...

Four in 10 Adults With Diabetes Report Taking a GLP-1 Receptor Agonist

TUESDAY, May 14, 2024 – One in eight adults (12 percent) say they have ever taken a glucagon-like peptide-1 receptor agonist (GLP-1 RA) and 6 percent say they are currently using one, according to...

GLP-1 Receptor Agonist Use Increases Likelihood of Antidepressant Prescription

WEDNESDAY, May 15, 2024 – Individuals taking glucagon-like peptide (GLP)-1 receptor agonists have a greater risk for subsequently being dispensed antidepressants, according to a study published...

More Studies Support Wegovy's Long-Term Weight-Loss Benefits

TUESDAY, May 14, 2024 – Semaglutide – the active ingredient in the blockbuster weight-loss drugs Ozempic and Wegovy – can produce long-term weight and heart health benefits, a pair of new studies...

One in 8 U.S. Adults Have Now Used Blockbuster Meds Like Ozempic

FRIDAY, May 10, 2024 – About 1 in 8 U.S. adults (12%) have tried a weight-loss drug like Wegovy, Ozempic, Zepbound or Mounjaro, a new KFF Health Tracking Poll says. About 6% are taking one right...

Semaglutide Alleviates Metabolic-Linked Liver Disease in People With HIV

TUESDAY, April 30, 2024 – For people with HIV (PWH), semaglutide is effective for metabolic dysfunction-associated steatotic liver disease (MASLD), according to a research letter published online...

GLP1 Receptor Agonist Use Does Not Seem to Increase Risk for Thyroid Cancer

WEDNESDAY, April 24, 2024 – Glucagon-like peptide 1 (GLP1) receptor agonist use does not appear to be associated with an increased risk for thyroid cancer, according to a study published online...

Endoscopic Sleeve Gastroplasty Is Cost Saving Versus Semaglutide

FRIDAY, April 12, 2024 – For individuals with class II obesity, endoscopic sleeve gastroplasty (ESG) is cost saving compared with semaglutide, according to a study published online April 12 in JAMA...

Aspiration Pneumonia Risk Increased for GLP-1 RA Users Undergoing Endoscopy

FRIDAY, April 12, 2024 – Patients using glucagon-like peptide 1 receptor agonists (GLP-1 RAs) undergoing endoscopic procedures have an increased risk for aspiration pneumonia, according to a study...

Ozempic, Wegovy Won't Boost Thyroid Cancer Risk: Study

WEDNESDAY, April 10, 2024 – Wegovy, Ozempic and other drugs known as GLP-1 analogues have become wildly popular for controlling diabetes and helping folks lose weight. There were concerns that...

ACC: Semaglutide Beneficial in Obesity-Related Heart Failure, Type 2 Diabetes

TUESDAY, April 9, 2024 – Semaglutide leads to larger reductions in heart failure-related symptoms and physical limitations among patients with obesity-related heart failure with preserved ejection...

Another Study Warns of Surgery Risks for Folks Taking Ozempic, Wegovy

FRIDAY, March 29, 2024 – People taking weight-loss drugs like Ozempic and Wegovy need to drop them in the days or weeks prior to surgery, a new study warns. Folks on one of these drugs – known as...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Cardiovascular Risk Reduction, Diabetes, Type 2

Ozempic patient information at Drugs.com